Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1614 1616 1617 1628 1658
This examiner grants 36% of resolved cases
Katherine Peebles operates in Tech Center 1600 and Art Unit 1614, where she has handled 515 resolved cases. Her allowance rate is 35.5%, which indicates a rigorous examination process. The median days to allowance for successful applications is 1177. A significant feature of her profile is the interview lift of 48.6%.
This high lift suggests that conducting an interview is a very effective strategy for increasing the probability of an allowance. Practitioners should strongly consider requesting an interview to address any rejections or objections. With 515 resolved cases, the data provides a clear indication of the examiner's tendencies. The combination of a 35.5% allowance rate and a 1177-day timeline suggests that securing a patent in Art Unit 1614 under this examiner requires a strong technical case. However, the 48.6% interview lift highlights that direct communication is a powerful tool for advancing prosecution toward a favorable outcome. These 515 resolutions provide a robust data set for strategic planning.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 15962327 | COMPOSITIONS WITH ANIONIC AND CATIONIC POLYMERS HAVING IMPROVED BENEFITS | Final Rejection | The Procter & Gamble Company |
| 18790293 | HEMOGLOBIN-BASED NANOPARTICLES | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18764882 | CHLORITE USES FOR STEM CELLS | Non-Final OA | The Regents of the University of California |
| 18393618 | KNITTED CELL SCAFFOLDS | Final Rejection | Massachusetts Institute of Technology |
| 17346615 | STABLE IODINE-CONTAINING ANTIMICROBIAL TEAT DIP COMPOSITIONS | Final Rejection | ECOLAB USA INC. |
| 18705455 | SPRAY-DRIED COMPOSITIONS AND METHODS OF PREPARATION | Final Rejection | NATIONAL UNIVERSITY OF SINGAPORE |
| 18952148 | COSMETIC COMPOSITIONS | Non-Final OA | L'OREAL |
| 18719683 | COMPOSITION COMPRISING HYALURONIC ACID-BASED POLYION COMPLEX PARTICLE AND SURFACTANT | Final Rejection | L'Oreal |
| 18719700 | PROCESS FOR LIGHTENING OR SIMULTANEOUSLY BLEACHING AND DYEING KERATIN FIBRES | Non-Final OA | L'OREAL |
| 17601331 | COSMETIC PREPARATION CONTAINING ULTRAVIOLET WAVELENGTH CONVERSION MATERIAL AND WATER-SOLUBLE THICKENING AGENT | Non-Final OA | Shiseido Company, Ltd. |
| 18719387 | COSMETIC SWEAT MANAGEMENT COMPOSITIONS | Final Rejection | Conopco, Inc., d/b/a UNILEVER |
| 18715134 | A SKIN CARE COMPOSITION | Final Rejection | Conopco, Inc., d/b/a UNILEVER |
| 18024509 | TREATMENTS OF DIABETIC ULCERS, RELATED COMPOSITIONS AND KITS | Non-Final OA | IMPERIAL COLLEGE INNOVATIONS LIMITED |
| 18278176 | SURFACE-MODIFIED ZINC OXIDE PARTICLES, DISPERSION LIQUID, COSMETIC PREPARATION, AND METHOD FOR PRODUCING SURFACE-MODIFIED ZINC OXIDE PARTICLES | Final Rejection | SUMITOMO OSAKA CEMENT CO., LTD. |
| 18410924 | COSMETIC COMPOSITION FOR IMPROVING SENSITIVE SKIN | Non-Final OA | LG HOUSEHOLD & HEALTH CARE LTD. |
| 17918790 | NASAL SPRAY FORMULATION WITH MOISTURIZING BENEFITS | Final Rejection | Haleon US Holdings LLC |
| 18731125 | MANUFACTURING METHODS FOR GASTRIC RESIDENCE SYSTEMS | Non-Final OA | Nortiva Bio, Inc. |
| 18272786 | GASTRIC RESIDENCE SYSTEMS FOR ADMINISTRATION OF RISPERIDONE | Final Rejection | Nortiva Bio, Inc. |
| 17798019 | COSMETIC PRODUCT | Final Rejection | BAKEL S.R.L. |
| 17180539 | SYSTEMS AND METHODS FOR STERILIZING IODOPHOR COMPOSITIONS | Final Rejection | CareFusion Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy